share_log

One Health Catalyst Insider Raised Their Stake In The Previous Year

One Health Catalyst Insider Raised Their Stake In The Previous Year

一名Health Catalyst內部人士在上一年增加了他們的股份
Simply Wall St ·  08/22 21:35

Looking at Health Catalyst, Inc.'s (NASDAQ:HCAT ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold.

從過去一年來看,我們可以看到Health Catalyst公司(納斯達克:HCAt)的內部交易情況,內部人員的淨買入股票數量多於賣出股票的數量。

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

儘管我們永遠不會建議投資者僅基於公司董事的行動做出決策,但邏輯推斷您應該關注內部人士是否買賣股票。

The Last 12 Months Of Insider Transactions At Health Catalyst

Health Catalyst過去12個月內的內部交易情況如下

In the last twelve months, the biggest single purchase by an insider was when CEO & Director Daniel Burton bought US$205k worth of shares at a price of US$7.81 per share. So it's clear an insider wanted to buy, even at a higher price than the current share price (being US$7.15). While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We always take careful note of the price insiders pay when purchasing shares. Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price. Daniel Burton was the only individual insider to buy shares in the last twelve months.

在過去的12個月中,首席執行官兼董事Daniel Burton以每股7.81美元的價格購買了總價值20.5萬美元的股票,這是內部人員的最大單筆購買。因此,很明顯,內部人員希望購買,即使價格高於當前股價(爲7.15美元)。雖然他們的觀點可能在購買後發生了變化,但至少這表明他們對公司的未來有信心。我們始終會注意內部人員購買股票時支付的價格。一般來說,當內部人員以高於當前價格的價格購買股票時,我們會對此表示關注,因爲這表明他們認爲這些股票值得購買,即使價格較高。在過去的十二個月中,Daniel Burton是唯一一個購買股票的個人內部人員。

The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

下面的圖表顯示了過去一年內公司和個人的內部交易情況。如果您想確切地知道誰以多少價錢在何時賣出,請單擊下面的圖表!

1724333721054
NasdaqGS:HCAT Insider Trading Volume August 22nd 2024
納斯達克股票市場: health catalyst 2024年8月22日內部交易量

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.

還有很多其他的公司,公司的內部人士正在購買股票。你可能不想錯過這個免費的小市值公司的低估列表。

Insider Ownership Of Health Catalyst

health catalyst的內部持股情況

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. We usually like to see fairly high levels of insider ownership. It appears that Health Catalyst insiders own 2.6% of the company, worth about US$11m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

查看公司內部持股總量可以幫助你判斷他們與普通股東是否高度一致。我們通常希望看到相對較高的內部持股。似乎health catalyst內部人員擁有公司的2.6%的股份,價值約1100萬美元。這種內部持股水平很不錯,但稍微有些不夠突出。它確實表明了合理的一致性程度。

So What Do The Health Catalyst Insider Transactions Indicate?

那麼health catalyst的內部交易意味着什麼呢?

The fact that there have been no Health Catalyst insider transactions recently certainly doesn't bother us. On a brighter note, the transactions over the last year are encouraging. Insiders do have a stake in Health Catalyst and their transactions don't cause us concern. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Health Catalyst. For example - Health Catalyst has 3 warning signs we think you should be aware of.

最近沒有health catalyst的內部交易事實並不讓我們擔憂。更值得一提的是,過去一年的交易情況令人鼓舞。內部人員對health catalyst有一定的利益,並且他們的交易並不讓我們擔憂。此外,除了了解正在進行的內部交易,還有助於識別health catalyst面臨的風險。例如-我們認爲health catalyst存在3個警示跡象,你應該注意。

Of course Health Catalyst may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

當然,Health Catalyst可能不是最好買的股票。所以你可能希望看看這個免費精選的高質量公司合集。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論